Guidance for Edwards Lifesciences Corp. (EW)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
2024 | $2.70 – $2.80 | $2.75 | $6.30B – 6.60B | $6.48B | = Maintained | Details |
Q1 2024 | $0.62 – $0.66 | $0.67 | $1.53B – 1.61B | $1.56B | = Maintained | Details |
2023 | $2.50 – $2.60 | $2.55 | $5.90M – 6.10M | $5.96M | = Maintained | Details |
2023 | $2.48 – $2.60 | $2.52 | $5.60B – 6.00B | $5.85B | Raised | Details |
Q4 2023 | N/A | N/A | $1.45B – 1.53B | $1.54B | Lowered | Details |
Q3 2023 | $0.55 – $0.61 | $0.63 | $1.44M – 1.52M | $1.47M | Lowered | Details |
Q2 2023 | $0.62 – $0.68 | $0.63 | $1.48B – 1.56B | $1.46B | = Maintained | Details |
2022 | $2.50 – $2.65 | $2.58 | $5.50B – 6.00B | $5.82B | = Maintained | Details |
2022 | $2.40 – $2.50 | $2.52 | N/A | N/A | = Maintained | Details |
2022 | $2.50 – $2.65 | $2.55 | $5.50B – 6.00B | $5.76B | = Maintained | Details |
Q3 2022 | $0.58 – $0.66 | $0.65 | $1.30B – 1.37B | $1.44B | Lowered | Details |
Q2 2022 | $0.61 – $0.69 | $0.65 | $1.36B – 1.44B | $1.46B | = Maintained | Details |
Q1 2022 | $0.54 – $0.62 | $0.60 | $1.27B – 1.35B | $1.36B | = Maintained | Details |
2021 | $2.00 – $2.10 | $2.15 | $4.90B – 5.30B | $5.09B | Lowered | Details |
2021 | $2.07 – $2.27 | $2.13 | N/A | N/A | = Maintained | Details |
2021 | $2.07 – $2.27 | $2.21 | $5.20B – 5.40B | $5.17B | Raised | Details |
Q4 2021 | $0.53 – $0.59 | $0.56 | $1.30B – 1.38B | $1.41B | = Maintained | Details |
Q1 2021 | $0.43 – $0.53 | $0.50 | $1.10B – 1.20B | $1.21B | Lowered | Details |
2020 | $6.15 – $6.40 | $6.16 | $4.60B – 5.00B | $4.78B | = Maintained | Details |
2020 | $4.75 – $5.25 | $5.10 | $4.00B – 4.50B | $4.37B | Lowered | Details |
2020 | $1.85 – $1.95 | $1.84 | N/A | N/A | Raised | Details |
2020 | $1.75 – $1.95 | $1.63 | $4.00B – 4.50B | $4.23B | = Maintained | Details |
Q3 2020 | N/A | N/A | $1.00B – 1.20B | $1.04B | = Maintained | Details |
2019 | $5.10 – $5.35 | $5.21 | N/A | N/A | Raised | Details |
2019 | $5.20 – $5.40 | $5.29 | $4.00B – 4.30B | $4.16B | = Maintained | Details |
2019 | $5.05 – $5.30 | $5.21 | N/A | N/A | = Maintained | Details |
2019 | $5.50 – $5.65 | $5.34 | $4.00B – 4.30B | $4.23B | = Maintained | Details |
Q3 2019 | $1.13 – $1.23 | $1.25 | $1.02B – 1.06B | $1.02B | = Maintained | Details |
Q1 2019 | $1.15 – $1.25 | $1.30 | $950.00M – 1.01M | $997.57M | = Maintained | Details |
2018 | $1.05 – $1.15 | $1.17 | N/A | N/A | = Maintained | Details |
2018 | $4.43 – $4.63 | N/A | $900.00M – 950.00M | N/A | Raised | Details |
2018 | $4.50 – $4.70 | $4.54 | N/A | N/A | = Maintained | Details |
2018 | $4.60 – $4.75 | $4.63 | $3.50B – 3.90B | $3.84B | = Maintained | Details |
Q4 2018 | $1.05 – $1.20 | $1.21 | $950.00M – 1000.00M | $995.40M | = Maintained | Details |
Q3 2018 | $0.93 – $1.03 | $1.08 | $900.00M – 950.00M | $933.98M | = Maintained | Details |
Q1 2018 | $1.04 – $1.14 | N/A | $3.50B – 3.90B | N/A | Raised | Details |
2017 | $3.65 – $3.85 | $3.53 | N/A | N/A | Raised | Details |
2017 | $3.65 – $3.85 | $3.78 | $3.20B – 3.40B | $3.39B | = Maintained | Details |
Q4 2017 | $0.84 – $0.94 | $0.91 | $855.00M – 895.00M | $871.90M | = Maintained | Details |
Q3 2017 | $0.80 – $0.90 | $0.83 | N/A | N/A | = Maintained | Details |
Q2 2017 | $0.82 – $0.92 | N/A | $810.00M – 850.00M | N/A | = Maintained | Details |
Q1 2017 | $0.79 – $0.89 | $0.81 | $760.00M – 800.00M | $778.10M | = Maintained | Details |
2016 | $2.67 – $2.77 | $2.68 | $2.70B – 3.00B | $2.80B | Raised | Details |
2016 | $2.78 – $2.88 | $2.76 | N/A | N/A | Raised | Details |
2016 | $2.57 – $2.67 | $2.40 | N/A | N/A | Raised | Details |
2016 | $2.82 – $2.92 | $2.88 | $2.70B – 3.00B | $2.94B | = Maintained | Details |
Q4 2016 | $0.67 – $0.77 | $0.74 | $750.00M – 790.00M | $801.14M | = Maintained | Details |
Q2 2016 | $0.67 – $0.73 | $0.67 | $700.00M – 740.00M | $698.30M | = Maintained | Details |
2015 | $4.10 – $4.30 | $4.21 | $2.30B – 2.50B | $2.40B | Raised | Details |
2015 | $4.00 – $4.30 | $4.03 | $2.30B – 2.50B | $2.40B | Raised | Details |
2015 | $4.30 – $4.40 | $4.28 | $2.30B – 2.50B | $2.41B | Raised | Details |
2015 | $4.43 – $4.53 | $4.37 | $2.30M – 2.50M | $2.44M | Raised | Details |
2015 | $0.92 – $1.00 | $0.98 | $580.00M – 620.00M | $587.10M | = Maintained | Details |
Q4 2015 | $1.11 – $1.21 | $1.14 | $620.00M – 660.00M | $630.20M | Raised | Details |
2014 | $3.00 | $3.07 | $2.05M – 2.25M | N/A | = Maintained | Details |
2014 | $3.24 – $3.34 | $3.19 | $2.05M – 2.25M | N/A | Raised | Details |
2014 | $3.33 – $3.39 | $3.30 | $2.05B – 2.25B | $2.24B | Raised | Details |
2014 | $3.10 | $3.06 | $2.05M – 2.25M | $2.16M | = Maintained | Details |
Q4 2014 | $0.89 – $0.95 | $0.95 | $575.00M – 615.00M | $586.91M | = Maintained | Details |
Q2 2014 | $0.71 – $0.81 | $0.76 | $525.00M – 565.00M | $543.16M | = Maintained | Details |
Q1 2014 | $0.61 – $0.71 | $0.71 | $500.00M – 550.00M | $525.60M | = Maintained | Details |
2013 | $3.21 – $3.31 | $3.27 | $2.10B – 2.20B | $2.14B | = Maintained | Details |
2013 | $3.00 – $3.10 | $3.27 | N/A | N/A | Lowered | Details |
Q4 2013 | $0.81 – $0.85 | $0.86 | $520.00M – 550.00M | $546.06M | = Maintained | Details |
Q3 2013 | $0.63 – $0.67 | $0.71 | $475.00M – 505.00M | $494.00M | = Maintained | Details |
Q1 2013 | $0.74 – $0.78 | $0.77 | $505.00M – 530.00M | $317.70M | = Maintained | Details |
2012 | $2.58 – $2.68 | $2.67 | N/A | N/A | Lowered | Details |
Q4 2012 | N/A | N/A | $490.00M – 520.00M | $504.80M | = Maintained | Details |
Q3 2012 | $0.57 – $0.61 | $0.65 | $465.00M – 485.00M | $483.80M | = Maintained | Details |
2011 | $2.01 – $2.07 | $1.95 | $1.66B – 1.74B | $1.63B | = Maintained | Details |
Q2 2011 | $0.49 – $0.51 | $0.47 | N/A | N/A | = Maintained | Details |
Q1 2011 | $0.40 – $0.42 | $0.44 | N/A | N/A | = Maintained | Details |
2010 | $1.81 – $1.83 | $1.80 | $1.44B – 1.46B | $1.44B | Raised | Details |